secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0001558370-21-015016
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q3 revenue $52.5M (+7% YoY), net loss $3.4M; cuts FY2021 guidance to $203.5-206M
--------------------------------------------------------------------------------

- Q3 revenue $52.5M (+7% YoY); net loss $3.4M ($0.17/share) vs net income $2.4M ($0.12) in Q3 2020.
- Non-GAAP net loss $1.6M; Adjusted EBITDA $4.1M, down from $6.2M a year ago.
- FY2021 revenue guidance cut to $203.5-206.0M (9-10% growth) from prior $216.3-224.5M (16-20%), citing Delta variant and labor shortages.
- Acquired AffloVest respiratory therapy on Sept 8, funded with $30M term loan and $25M revolver draw; AffloVest added $0.9M revenue in Q3.
- Cash $22.4M, total debt $55.0M under credit agreement as of Sept 30, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837021015016/0001558370-21-015016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837021015016/tcmd-20211108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-015016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer